Topics:

Rheumatology Network

Joint Focus: Spondyloarthritis

For the first time, two societies devoted to spondyloarthropathies have met in joint session. Rheumatology Network was on site to learn the latest from the SPARTAN-GRAPPA conference:
-- Progress toward new PsA criteria ,
-- Impending North American guidelines on spondyloarthropathies, and
-- The growing voice of PsA patients in defining outcomes.

Recent Content

Whatever is causing this woman's hip pain, her x-ray looks quite severe. The diagnosis was correct 40 years ago, but it couldn't be treated effectively then. What's the problem?

Outcomes in psoriatic arthritis should improve, representatives of the research body GRAPPA assert, now that patients are gaining a role in creating symptom measures and definitions.

Tell-tale bone lesions forecast knee pain in osteoarthritis over 8 years

In two large randomized trials an anti-IL 17A monoclonal antibody proves better for psoriasis than placebo or etanercept.

The FDA has approved an abuse-resistant version of oxycodone, Targiniq ER.

(VIDEO) A demonstration of injection technique, followed by narrated ultrasound images from an actual procedure, show how to use ultrasound to guide aspiration and injection of the tibiotalar joint.

Do European guidelines for axial spondylitis adequately address patient needs on the other side of the Atlantic?

By clicking Accept, you agree to become a member of the UBM Medica Community.